Stockreport

United Therapeutics Announces FDA Approval and Launch of Tyvaso® for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

United Therapeutics Corporation  (UTHR) 
Last united therapeutics corporation earnings: 4/29 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.unither.com/investor-relations
PDF SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 1, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and [Read more]